Statistics

Total Visits

Views
Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells. 202

Total Visits per Month

March 2016 April 2016 May 2016 June 2016 July 2016 August 2016 September 2016
Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells. 0 4 2 3 4 2 0

File Downloads

Views
ijo_34_4_1155_PDF published.pdf 82

Top Country Views

Views
United States 44
Canada 25
Germany 24
Sweden 21
China 17
France 11
United Kingdom 10
Russia 6
South Korea 5
India 2

Top City Views

Views
Nynäs 18
Miami Beach 17
Toronto 13
Beijing 7
Ottawa 6
Kansas City 5
Zhengzhou 5
Dundas 3
Seoul 3
Memphis 2